Roohi Mariam Peter, Author at Labiotech.eu

About

Having completed a master’s programme in International Journalism from Cardiff University in 2022, I have written about various subjects including culture, politics, social justice, mental health, LGBTQ+ issues and gender. My undergraduate degree in life sciences has equipped me to explore my passion for reporting on health, science and the environment. When I’m not transcribing interviews and fretting about deadlines, I like to spend my time reading, watching movies, and making lousy mixtapes for a potential side career in rap music.

Articles by Roohi Mariam Peter

Best in Biotech 10 Oct 2023

Bridging Science and Art: Five bioartists you should know about

Bioartists bridge art, born out of creativity and abstract thoughts, and science, which is rooted in facts, laws and logic, as a means of self-expression. The term bioart was coined by Brazilian-American artist Eduardo Kac, who implanted a microchip in his ankle on live television, and registered himself in a pet database, as both the […]

October 10, 2023 - 10 minutesmins - By Roohi Mariam Peter

In Depth 6 Oct 2023

Will the U.S. Cancer Moonshot program land its target to halve cancer death rates?

It was predicted that more than 600,000 people would die from cancer last year in the U.S., according to the American Cancer Society. But what if those figures could be halved over the next couple of decades? Although no small feat, that’s precisely what the Cancer Moonshot program aims to do. The White House initiative, […]

October 6, 2023 - 10 minutesmins - By Roohi Mariam Peter

In Depth 4 Oct 2023

CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?

Riding on the success of CAR-T cell therapy, a breakthrough in the treatment of blood cancers, CAR-NK therapies are an emerging field in therapeutic research that aim to boost an even stronger immune response against cancer. What is CAR-NK cell therapy? Natural killer (NK) cells, like T cells, are white blood cells that are a […]

October 4, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 2 Oct 2023

PIPEs in biotech fundraising: is this growing trend fueled by economic uncertainty here to stay?

This past year has not been very sympathetic to fundraisers in the biotech industry. As the economic downturn grinds on, many companies are in need of funds to stay afloat. A recent trend in the way biotechs have secured funding, might be telling of how these companies are determined to pull through. A private investment […]

October 2, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 29 Sep 2023

Illumina: DNA giant in troubled waters

A botched acquisition deal and unrest among company investors amid plummeting stocks have plagued Illumina, which was once part of the biotech big leagues that dominated the field of gene sequencing. Now, in fear of losing its ground to other players in the space, it has received a European Commission order to divest Grail, and […]

September 29, 2023 - 8 minutesmins - By Roohi Mariam Peter

In Depth 25 Sep 2023

Base editing hits the clinic in the U.S.

Over the past couple of years, base editing, a recent offshoot of the heralded CRISPR/Cas 9 technology, has been doing its rounds in the biotech space. Now, base editing has finally set foot into clinical trials for the first time in the U.S.. American precision medicine company Beam Therapeutics treated its first patient with its […]

September 25, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 22 Sep 2023

U.S. approval for psychedelic drug MDMA nears after success in clinic

The psychedelic drug MDMA edges closer towards FDA approval for the treatment of post-traumatic stress disorder (PTSD) in the U.S., after promising results of a trial were published. This comes after Australia became the first country to allow doctors to prescribe the drug to those struggling with mental health disorders like PTSD and depression. Recognizing […]

September 22, 2023 - 7 minutesmins - By Roohi Mariam Peter

Best in Biotech 21 Sep 2023

Recent advancements in prostate cancer research over the past year

Prostate cancer is the second most commonly occurring cancer in men. More than 1.4 million people were diagnosed with prostate cancer in 2020, according to the World Cancer Research Fund International. While some prostate cancers develop too slowly, to the extent that some people will not need any treatment during their lifetime, some grow very […]

September 21, 2023 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 18 Sep 2023

Rebuilding relations: U.K. rejoins Horizon Europe to boost funding opportunities

The U.K. is rejoining the European Union’s (EU’s) $100 billion research program Horizon Europe, after being locked out of the deal amid post Brexit tensions for more than two years. This comes after months of negotiations between the U.K. government and the EU, in an attempt to broaden opportunities for researchers in the U.K.. British […]

September 18, 2023 - 5 minutesmins - By Roohi Mariam Peter

In Depth 14 Sep 2023

Righting wrongs: genetic justice for Henrietta Lacks

For what would have been Henrietta Lacks’ 103rd birthday last month, her family, who settled a lawsuit with Thermo Fisher – a multinational biotech company that had used her cells without seeking consent for several years – regarded the win as a “fitting day” for justice. While the settlement took place behind closed doors, where Henrietta […]

September 14, 2023 - 7 minutesmins - By Roohi Mariam Peter

Best in Biotech 12 Sep 2023

Here are five biotech companies in Montreal to keep an eye on

Montreal, the largest city in Canada’s Quebec province, has seen a boom in life sciences over the years. Home to The Biotech City, a hub that connects and supports biopharmaceutical companies within the region as well as attracts talent from across the world, Montreal rivals the likes of Vancouver and Toronto, in being the leading […]

September 12, 2023 - 6 minutesmins - By Roohi Mariam Peter

Best in Biotech 5 Sep 2023

Five recent advancements in ovarian cancer research over the past year

With around 7500 new cases reported in the U.K. alone every year, ovarian cancer may occur because of the inheritance of faulty genes like BRCA. Although the exact reason for cancer-causing genetic mutations is unknown – as with all other kinds of cancer – ovarian cancer research has shown that the risk increases with age, […]

September 5, 2023 - 9 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Roohi Mariam Peter

About

Articles by Roohi Mariam Peter

Bridging Science and Art: Five bioartists you should know about

Will the U.S. Cancer Moonshot program land its target to halve cancer death rates?

CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?

PIPEs in biotech fundraising: is this growing trend fueled by economic uncertainty here to stay?

Illumina: DNA giant in troubled waters

Base editing hits the clinic in the U.S.

U.S. approval for psychedelic drug MDMA nears after success in clinic

Recent advancements in prostate cancer research over the past year

Rebuilding relations: U.K. rejoins Horizon Europe to boost funding opportunities

Righting wrongs: genetic justice for Henrietta Lacks

Here are five biotech companies in Montreal to keep an eye on

Five recent advancements in ovarian cancer research over the past year

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Roohi Mariam Peter

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!